Intraocular Inflammation Following Intravitreal Faricimab Injection in Neovascular Age-Related Macular Degeneration
Shweta Parakh, Vaibhav Bhatt, Shrutanjoy Das, Priksha Lakhlan, Gaurav Luthra, Saurabh Luthra · 2024
Read Intraocular Inflammation Following Intravitreal Faricimab Injection in Neovascular Age-Related Macular Degeneration by Shweta Parakh, Vaibhav Bhatt, Shrutanjoy Das, Priksha Lakhlan, Gaurav Luthra, Saurabh Luthra (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11742458.txt.
Description
Shweta Parakh and five co-authors report eye inflammation after injections of a newer drug for wet macular degeneration. Their report appeared in twenty twenty-four. The drug, faricimab, was given to three patients who had stopped responding to older agents.
Two patients developed mild inflammation of the eye's gel within three days. The third showed front-of-eye inflammation the day after injection. No vessel inflammation or blockage appeared. All three settled with steroid eye drops alone. One patient had reacted before to a related drug, hinting at an immune link. The authors urge vigilance, since the same reaction can, in worse forms, threaten sight.
Catalog record
| CREATOR | Shweta Parakh, Vaibhav Bhatt, Shrutanjoy Das, Priksha Lakhlan, Gaurav Luthra, Saurabh Luthra |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 15 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |